Late Events Occurring After 5 Years in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1867017444111941632 |
|---|---|
| author | Sara Kreimer Wei Xue Amira Qumseya Timothy B. Lautz Archana Shenoy Susan Hiniker Dana Casey Rajkumar Venkatramani Carola Arndt |
| author_facet | Sara Kreimer Wei Xue Amira Qumseya Timothy B. Lautz Archana Shenoy Susan Hiniker Dana Casey Rajkumar Venkatramani Carola Arndt Sara Kreimer Wei Xue Amira Qumseya Timothy B. Lautz Archana Shenoy Susan Hiniker Dana Casey Rajkumar Venkatramani Carola Arndt |
| collection | Wiley Open Access |
| contents | Late Events Occurring After 5 Years in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group Sara Kreimer Wei Xue Amira Qumseya Timothy B. Lautz Archana Shenoy Susan Hiniker Dana Casey Rajkumar Venkatramani Carola Arndt Pediatric Blood & Cancer ABSTRACTRhabdomyosarcoma is the most common pediatric soft tissue sarcoma, and 5‐year overall survival exceeds 70%. With more long‐term survivors, it is critical to understand the frequency of late events, including recurrence, second malignant neoplasm, and death, occurring 5 years after diagnosis, and the variables associated with these events. We report late events in patients enrolled on Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group trials from 1997 to 2013 including D9602, D9803, D9802, ARST0331, ARST0431, ARST0531, and ARST08P1. A late event occurred in 2.9% of 5‐year event‐free survivors supporting guidelines to limit surveillance for these events to 5 years from diagnosis. 10.1002/pbc.31421 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| doi_str_mv | 10.1002/pbc.31421 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_pbc_31421 |
| institution | Wiley Open Access |
| license_str_mv | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Late Events Occurring After 5 Years in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group Sara Kreimer Wei Xue Amira Qumseya Timothy B. Lautz Archana Shenoy Susan Hiniker Dana Casey Rajkumar Venkatramani Carola Arndt Pediatric Blood & Cancer Late Events Occurring After 5 Years in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group Sara Kreimer Wei Xue Amira Qumseya Timothy B. Lautz Archana Shenoy Susan Hiniker Dana Casey Rajkumar Venkatramani Carola Arndt Pediatric Blood & Cancer ABSTRACTRhabdomyosarcoma is the most common pediatric soft tissue sarcoma, and 5‐year overall survival exceeds 70%. With more long‐term survivors, it is critical to understand the frequency of late events, including recurrence, second malignant neoplasm, and death, occurring 5 years after diagnosis, and the variables associated with these events. We report late events in patients enrolled on Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group trials from 1997 to 2013 including D9602, D9803, D9802, ARST0331, ARST0431, ARST0531, and ARST08P1. A late event occurred in 2.9% of 5‐year event‐free survivors supporting guidelines to limit surveillance for these events to 5 years from diagnosis. 10.1002/pbc.31421 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| title | Late Events Occurring After 5 Years in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group |
| topic | Pediatric Blood & Cancer |
| url | https://onlinelibrary.wiley.com/doi/10.1002/pbc.31421 |